![]()
- 1. Hepatocyte TMEM16A Deletion Retards NAFLD Progression by Ameliorating Hepatic Glucose Metabolic Disorder.Advanced Science
- 2. 郭家伟, Macrophage NFATc3 prevents foam cell formation and atherosclerosis: evidence and mechanisms.EUROPEAN HEART JOURNAL,2021-09-27
- 3. 余捷,宋子豪,郭家伟,龚权,梁思佳,陀永华,裴飞,简正阳,周鹏禹,郑少忆,邹少伟,张峰,李承意,晋晨晨,段威,刘秀,刘莹莹,黄帅. Hepatocyte-specific TMEM16A deficiency alleviates hepatic ischemia/reperfusion injury via suppressing GPX4-mediated ferroptosis.CELL DEATH & DISEASE,2022-12-01
- 4. Transaldolase inhibits CD36 expression by modulating glutathione-p38 signaling, exerting protective effects against macrophage foam cell formation.Acta Biochimica et Biophysica Sinica
- 5. Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disease in mice.Journal of Hepatology
- 6. Ferroptosis: a potential target for the treatment of atherosclerosis.Acta Biochimica et Biophysica Sinica
- 7. Multifaceted role of ferroptosis in cardiovascular disease.Acta Biochimica et Biophysica Sinica
- 8. 宋子豪,郭家伟,龚权, Pyroptosis: Mechanisms and Links with Fibrosis.cells,2021-12-12,10(12)
